Mechanisms Up- and Down-Stream of Hypoxia-Inducible Factor in Acute Kidney Injury
Mechanisms Up- and Down-Stream of Hypoxia-Inducible Factor in Acute Kidney Injury
批准号:
192653319
负责人:
Professor Dr. Michael Fähling
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Units
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2017-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
At present, no specific therapy exists for either evolving or established acute kidney injury (AKI). Altered regional renal hemodynamics play an important role in AKI. Recent studies, including those from our group, suggest that activation of hypoxia-inducible transcription factors (HIFs) can alleviate experimental AKI. Most of these studies used renal artery clamping to induce ischemia and reperfusion injury (I/RI). Importantly, HIF activation was commonly achieved before the onset of AKI. The potential impact on renal hemodynamics has not been studied. In a preliminary study in transgenic mice, we found that activation of HIF through an inducible knockout of the von Hippel Lindau protein (pVHL), starting 4 wk before the insult, enhances renal tubulo-interstitial capillarization and ameliorates acute tubular injury in experimental rhabdomyolysis. The rhabdomyolosis model closely resembles the human syndrome of AKI induced by crush injury. In the present proposal, we attempt to investigate 1) whether renal protection may be achieved with HIF activation shortly before or even after the onset of injury, 2) which HIF target genes associate with protection from AKI, 3) the contribution of improved capillarization to renal protection, 4) the potential role of novel non-invasive magnetic resonance imaging techniques for early diagnose, risk stratification, and control of HIF activating therapy in AKI, 5) the effects of myoglobin and HIF on glomerular hemodynamics. Taken together, this study will evaluate the therapeutic potential of HIF activation in a clinically representative mouse model of AKI.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?
糖尿病肾病的选择性内皮素抑制:是锦上添花吗?
DOI:
10.1111/apha.12332
发表时间:
2014
期刊:
Acta Physiologica
影响因子:
6.3
作者:
[Rosenberger C, Fähling M]
通讯作者:
Fähling M
DOI:
10.1038/ki.2014.362
发表时间:
2015-04
期刊:
Kidney international
影响因子:
19.6
作者:
[M. Khamaisi;Hala Toukan;J. Axelrod;C. Rosenberger;G. Skarzinski;A. Shina;R. Meidan;R. Koesters;S. Rosen;G. Walkinshaw;I. Mimura;M. Nangaku;S. Heyman]
通讯作者:
M. Khamaisi;Hala Toukan;J. Axelrod;C. Rosenberger;G. Skarzinski;A. Shina;R. Meidan;R. Koesters;S. Rosen;G. Walkinshaw;I. Mimura;M. Nangaku;S. Heyman
DOI:
10.1111/apha.12811
发表时间:
2017-03-01
期刊:
ACTA PHYSIOLOGICA
影响因子:
6.3
作者:
[Fahling, M., Mathia, S., Rosenberger, C.]
通讯作者:
Rosenberger, C.
Posttranskriptionelle Kontrolle der Genexpression des bHLH-Transkriptionsfaktors Mash1
-
批准号:59635408
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Michael Fähling
-
依托单位:
国内基金
海外基金
登录
查看更多内容
“Bottom-up”策略构筑金属纳米粒子-多孔有机聚合物复合催化材料
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:张勇
-
依托单位:
碳锰双功能催化剂低温协同脱除烧结烟气NOx与UP-POPs研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:苏伟
-
依托单位:
基于MS/MS和UP-MMCA的新生儿甲基丙二酸血症二阶筛查新方法构建与临床应用研究
-
批准号:82101824
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:王旭东
-
依托单位:
简便快速bottom-up法制备含氮空位中心的纳米金刚石晶体
-
批准号:51972035
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:唐春玖
-
依托单位:
简便快速bottom-up法制备含氮空位中心的纳米金刚石晶体
-
批准号:--
-
项目类别:面上项目
-
资助金额:60万元
-
批准年份:2019
-
负责人:唐春玖
-
依托单位:
长效GnRHa“flare-up”效应通过AMPK通路抑制子宫腺肌症患者卵泡发育的机制
-
批准号:81801418
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:陆小溦
-
依托单位:
基于MOFs衍生的多孔纳米复合金属氧化物的制备及其低温催化降解UP-POPs机理研究
-
批准号:21777159
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2017
-
负责人:樊芸
-
依托单位:
多功能载紫杉醇靶向磁性纳米粒UP-MNP-C11诊治动脉粥样硬化的实验研究
-
批准号:81270413
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:刘崎
-
依托单位:
基于MAS/UP模型的城市“四规合一”研究——以朝阳区为实证
-
批准号:71203212
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2012
-
负责人:王俭
-
依托单位:
手性有机多孔材料:“Bottom-Up”策略实现手性有机小分子催化剂的多相化
-
批准号:21172103
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2011
-
负责人:王为
-
依托单位: